Company profile: Daktari Diagnostics
1.1 - Company Overview
Company description
- Provider of diagnostic medical products for clinicians and patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Daktari Diagnostics
NRx Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage therapeutics targeting central nervous system disorders and pulmonary diseases, with investigational products including NRX-101 for suicidal bipolar depression (Phase 3), chronic pain (Phase 2), and PTSD (Phase 2), and NRX-100 (IV ketamine) for severe bipolar depression post stabilization from a suicidal crisis (Phase 3).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NRx Pharmaceuticals company profile →
Cavidi
HQ: Sweden
Website
- Description: Provider of HIV viral load monitoring diagnostics and BOLD-based immunoassay signal amplification solutions, including Exazym reagent kits for attomole-level biomarker detection (up to 100x amplification), ClickChem conjugation, polymerase reaction and biotin detection kits, plus research services and collaborations on low-abundance biomarker discovery and immunoassay development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cavidi company profile →
60 Degrees Pharmaceuticals
HQ: United States
Website
- Description: Provider of medicines to treat and prevent infectious diseases, including ARAKODA (tafenoquine) for malaria prophylaxis in patients 18+, a Dengue Fever Treatment Program developing 60P001 (alpha-glucosidase inhibitor) and 60P002 (platelet-activating factor receptor antagonist), and a Malaria Prevention Program developing new drugs to address limitations of existing prophylactics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 60 Degrees Pharmaceuticals company profile →
BioHelix
HQ: United States
Website
- Description: Provider of simple molecular diagnostic tests for the near patient setting, developed to improve the quality of healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioHelix company profile →
Allecra Therapeutics
HQ: Germany
Website
- Description: Provider of clinical-stage biopharmaceutical treatments for multi-drug-resistant bacterial infections, including cefepime/enmetazobactam for complicated urinary tract infections and ESBL-producing pathogens, and enmetazobactam, a novel β-lactamase inhibitor with potent activity against Class A serine β-lactamases that enhances the effectiveness of cefepime.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allecra Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Daktari Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Daktari Diagnostics
2.2 - Growth funds investing in similar companies to Daktari Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Daktari Diagnostics
4.2 - Public trading comparable groups for Daktari Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →